Team:Paris/August 18
From 2008.igem.org
(Difference between revisions)
(→Ligation) |
(→Miniprep and stock glycerol of L151) |
||
Line 20: | Line 20: | ||
- | =='''Miniprep and stock glycerol | + | =='''Miniprep and stock glycerol'''== |
*[[Team:Paris/Notebook/Protocols#Glycerol stocks| Protocol stocks]] | *[[Team:Paris/Notebook/Protocols#Glycerol stocks| Protocol stocks]] | ||
{|border="1" style="text-align: center" | {|border="1" style="text-align: center" | ||
|'''Stock number''' | |'''Stock number''' | ||
- | |||
|'''Biobricks''' | |'''Biobricks''' | ||
|'''Description''' | |'''Description''' | ||
|- | |- | ||
- | | | + | |S163.1 |
- | + | |rowspan="2"| B0032 | |
- | |rowspan=" | + | |rowspan="2"| RBS |
- | |rowspan=" | + | |
|- | |- | ||
- | | | + | |S163.2 |
- | + | ||
|- | |- | ||
- | | | + | |S164.1 |
- | | | + | |rowspan="2"| E0422 |
+ | |rowspan="2"| RBS+ ECFP+ LVA+ term | ||
+ | |- | ||
+ | |S164.2 | ||
+ | |- | ||
+ | |S165.1 | ||
+ | |rowspan="2"| E0430 | ||
+ | |rowspan="2"| RBS+ YFP+ LVA- term | ||
+ | |- | ||
+ | |S165.2 | ||
+ | |- | ||
+ | |S166.1 | ||
+ | |rowspan="2"| E0432 | ||
+ | |rowspan="2"| RBS+ YFP LVA+ term | ||
+ | |- | ||
+ | |S166.2 | ||
+ | |- | ||
+ | |S167.1 | ||
+ | |rowspan="2"| E0420 | ||
+ | |rowspan="2"| RBS+ ECFP LVA- term | ||
+ | |- | ||
+ | |S167.2 | ||
+ | |- | ||
+ | |S168.1 | ||
+ | |rowspan="2"| I732078 | ||
+ | |rowspan="2"| RBS+ mRFP LVA+ term | ||
+ | |- | ||
+ | |S168.2 | ||
|} | |} | ||
- | *[[Team:Paris/Notebook/Protocols#Minipreps (Kit_Qiagen)| Protocol | + | *[[Team:Paris/Notebook/Protocols#Minipreps (Kit_Qiagen)| Protocol Miniprep]] |
- | + | ||
{|border="1" style="text-align: center" | {|border="1" style="text-align: center" | ||
- | |''' | + | |'''Stock number''' |
- | + | ||
- | + | ||
|'''Biobricks''' | |'''Biobricks''' | ||
|'''Description''' | |'''Description''' | ||
|- | |- | ||
- | | | + | |MP163.1 |
- | | | + | |B0032 |
- | | | + | |- |
- | | | + | |MP163.2 |
- | | | + | |B0032 |
+ | |- | ||
+ | |MP164.1 | ||
+ | |E0422 | ||
+ | |- | ||
+ | |MP164.2 | ||
+ | |E0422 | ||
+ | |- | ||
+ | |MP165.1 | ||
+ | |E0430 | ||
+ | |- | ||
+ | |MP165.2 | ||
+ | |E0430 | ||
+ | |- | ||
+ | |MP166.1 | ||
+ | |E0432 | ||
+ | |- | ||
+ | |MP166.2 | ||
+ | |E0432 | ||
+ | |- | ||
+ | |MP167.1 | ||
+ | |E0420 | ||
+ | |- | ||
+ | |MP167.2 | ||
+ | |E0420 | ||
|- | |- | ||
- | | | + | |MP168.1 |
- | | | + | |I732078 |
|- | |- | ||
- | | | + | |MP168.2 |
- | | | + | |I732078 |
|} | |} | ||
Revision as of 17:31, 20 August 2008
Analysis of the cloning of OmpR* and EnvZ*PCR screening
Reaction mixture (25 µL total volume)
We wanted to analyse the transformants of the ligations L133 (OmpR* in pSB1A2) and L134 (EnvZ* in pSB1A2) from the experience of august 9th/11th.
Miniprep and stock glycerol
Digestion of MP162Measurement of the concentration of MPs 162
Digestion
Gel Extraction
Ligation
Culture of stable strains with biobrocks 2008 |